Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


NuVasive reported $300.54M in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
Abbott ABT:US USD 8.24B 549M
Baxter International BAX:US USD 3.46B 233M
Becton, Dickinson and Co. BDX:US USD 4.19B 192M
Boston Scientific BSX:US USD 2.84B 3M
Cooper Companies COO:US USD 781.1M 72.1M
Dexcom DXCM:US USD 694.3M 4.5M
Edwards Lifesciences EW:US USD 1.07B 170.7M
Globus Medical GMED:US USD 220.28M 185K
Haemonetics HAE:US USD 269.16M 7.14M
Hologic HOLX:US USD 754.4M 57.4M
Insulet PODD:US USD 330.4M 15.8M
Integra LifeSciences IART:US USD 343.96M 6.45M
Intuitive Surgical ISRG:US USD 1.31B 26.1M
J&J JNJ:US USD 25.48B 5.98B
Merit Medical Systems MMSI:US USD 271.18M 8.18M
NuVasive NUVA:US USD 300.54M 16.74M
Stryker SYK:US USD 4.04B 345M
Tandem Diabetes Care TNDM:US USD 297.2M 58.92M
Teleflex TFX:US USD 595.96M 33.9M
Zimmer Biomet Holdings Inc ZBH:US USD 1.5B 349.7M